soul trial oral semaglutide cardiovascular outcomes 2024 nejm and in Type 2 Diabetes Long-term kidney outcomes of semaglutide

This is an extreme overdose scenario, not typical of standard protocols

3 Adverse events in PIONEER 2 1,3 Comparator AE rates are not an adequate basis for comparison of safety between products 1 Because clinical trials are conducted under widely varying conditions, AE rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice 1 AE=adverse event

Your prescriber will approve or disapprove of Wegovy treatment at their discretion after careful consideration of your unique health profile

That makes them the right first active if you are new to the category